Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting.

Jeste DV, Klausner M, Brecher M, Clyde C, Jones R.

Psychopharmacology (Berl). 1997 Jun;131(3):239-47.

PMID:
9203234
[PubMed - indexed for MEDLINE]
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

Development and implementation of drug use evaluation (DUE) criteria for risperidone in an outpatient psychiatric setting.

Shepski JC, Wincor MZ, Gutierrez MA, Gross LS.

Psychopharmacol Bull. 1996;32(4):705-19. Review.

PMID:
8993094
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk